These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27207892)

  • 1. New Drugs Prompt Myeloma Guidelines Update.
    Cancer Discov; 2016 Jul; 6(7):684. PubMed ID: 27207892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloma researchers gain genome, new targets, and new concerns.
    Brower V
    J Natl Cancer Inst; 2011 Jul; 103(14):1082-5. PubMed ID: 21737696
    [No Abstract]   [Full Text] [Related]  

  • 3. [New drugs in the treatment of multiple myeloma].
    Oriol A; Motlló C
    Med Clin (Barc); 2014 Sep; 143(6):268-74. PubMed ID: 24342015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into therapeutic targets in myeloma.
    Anderson KC
    Hematology Am Soc Hematol Educ Program; 2011; 2011():184-90. PubMed ID: 22160032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of clinical trials of novel agents for multiple myeloma].
    Kuroda J
    Rinsho Ketsueki; 2014 Oct; 55(10):2005-15. PubMed ID: 25297766
    [No Abstract]   [Full Text] [Related]  

  • 6. Lenalidomide and its role in the management of multiple myeloma.
    Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical and clinical evaluation of elotuzumab, a SLAMF7-targeted humanized monoclonal antibody in development for multiple myeloma.
    Palumbo A; Sonneveld P
    Expert Rev Hematol; 2015 Aug; 8(4):481-91. PubMed ID: 26070331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New treatments for multiple myeloma.
    Richardson PG; Schlossman R; Hideshima T; Anderson KC
    Oncology (Williston Park); 2005 Dec; 19(14):1781-92; discussion 1792, 1795-7. PubMed ID: 16506632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on proteasome inhibitors in multiple myeloma.
    Richardson PG
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):179-81. PubMed ID: 24927266
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of therapy for relapsed/refractory multiple myeloma: focus on lenalidomide.
    Mariz JM; Esteves GV
    Curr Opin Oncol; 2012 Jan; 24 Suppl 2():S3-11. PubMed ID: 22245806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of untreated multiple myeloma patients ineligible for autologous stem cell transplantation].
    Tsurumi H
    Rinsho Ketsueki; 2014 Oct; 55(10):2027-35. PubMed ID: 25297768
    [No Abstract]   [Full Text] [Related]  

  • 12. CD38 Monoclonal Antibody Therapies for Multiple Myeloma.
    Wong SW; Comenzo RL
    Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):635-45. PubMed ID: 26443328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is there any real progress in the chemotherapy of multiple myeloma?].
    Bataille R
    Rev Med Interne; 1985 Oct; 6(4):419-26. PubMed ID: 3906819
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple Myeloma: Multiplying Therapies.
    Bates SE
    Clin Cancer Res; 2016 Nov; 22(22):5418. PubMed ID: 28151708
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel approaches to the management of myeloma.
    Rajkumar SV
    Oncology (Williston Park); 2005 Apr; 19(5):621-5. PubMed ID: 15948290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approves new agent for multiple myeloma.
    Fenichel MP
    J Natl Cancer Inst; 2015 Jun; 107(6):djv165. PubMed ID: 26032612
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoclonal antibodies - A new era in the treatment of multiple myeloma.
    Jelinek T; Hajek R
    Blood Rev; 2016 Mar; 30(2):101-10. PubMed ID: 26362528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Treatments and Insights in Multiple Myeloma.
    Faiman B; Noonan K
    ONS Connect; 2016 Jun; 31(6):4 p following 31. PubMed ID: 27430103
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy of myeloma: drug combinations versus single agents, an overview, and comments on acute leukemia in myeloma.
    Bergsagel DE
    Hematol Oncol; 1988; 6(2):159-66. PubMed ID: 3292373
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibodies in myeloma.
    Sondergeld P; van de Donk NW; Richardson PG; Plesner T
    Clin Adv Hematol Oncol; 2015 Sep; 13(9):599-609. PubMed ID: 26452191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.